Q&A with Barbara Cappelli: HLA- Sibling Transplants Works in Sickle Cell Disease

Barbara Cappelli, MD, Eurocord International Registry, Paris, France, shared an overview from her team's study that found further evidence that for patients with severe sickle cell disease who have an HLA-identical sibling available as a donor, HSCT can be safe and effective.

“This data should help us early refer patients with severe sickle-cell disease for transplantation if they do have anHLA-identical sibling," said Cappelli